Uptake of 1-methyl-4-phenylpyridinium (MPP+) by the JAR human placental choriocarcinoma cell line: Comparison with 5-hydroxytryptamine

Placenta

Volumn 24, Issue 4, 2003, Pages 361-369

  Martel, F ^a   Keating, E ^a  

^a Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CARRIER PROTEIN; CORTICOSTERONE; CYANINE 863; DECYNIUM 22; DESIPRAMINE; EXTRANEURONAL MONOAMINE TRANSPORTER; FLUOXETINE; ORGANIC CATION TRANSPORTER 2; PROTEIN INHIBITOR; SEROTONIN; SEROTONIN TRANSPORTER; SODIUM ION; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CANCER CELL CULTURE; CATION TRANSPORT; CHORIOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC POTENTIAL; FEMALE; HUMAN; HUMAN CELL; IC 50; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEROTONIN UPTAKE; STATISTICAL ANALYSIS; TEMPERATURE DEPENDENCE; TIME;

EID: 0038131135     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0917     Document Type: Article

References (47)

1. +) in the rat. Eur J Pharmacol, 141, 309-312.
2. Balkowetz DF, Tiruppathi C, Leibach FH, Mahesh VB & Ganapathy V (1989) Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J Biol Chem, 264, 2195-2198.
3. + and paraquat in Rana pipiens. Life Sci, 37, 1529-1538.
4. Bergmeyer HU & Bernt E (1974) Lactate dehydrogenase. In Methods in Enzymatic Analysis (Ed.) Bergmeyer HU, pp. 574-579. New York: Academic Press.
5. Bradford MM (1976) A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248-254.
6. Cool DR, Leibach FH, Bhalla VK, Mahesh VB & Ganapathy V (1991) Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J Biol Chem, 266, 15750-15757.
7. + after administration of lethal and sublethal doses of MPTP to mice. Toxicol Lett, 54, 253-262.
8. Gerlach M, Riederer P, Przuntek H & Youdim MBH (1991) MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol, 208, 273-286.
9. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE & Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol, 16, 871-881.
10. Gründemann D, Babin-Ebell J, Martel F, Örding N, Schmidt A & Schömig E (1997) Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem, 272, 10408-10413.
11. Gründemann D, Schechinger B, Rappold GA & Schömig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal monoamine transporter. Nat Neurosci, 1, 349-351.
12. Gründemann D, Liebich G, Kiefer N, Köster S & Schömig E (1999) Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol, 56, 1-10.
13. Javitch JA, D'Amato RJ, Strittmatter SM & Snyder SH (1985) Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridinium by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA, 82, 2173-2177.
14. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH & Ganapathy V (1998) Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem, 273, 15971-15979.
15. Kopin IJ (1992) Mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced destruction of dopaminergic neurons. In Selective Neurotoxicity (Handb Exp Pharmacol, Vol. 102) (Ed.) Herken H & Hucho F, pp. 333-356. Berlin: Springer-Verlag.
16. Kopin IJ (1993) The pharmacology of Parkinson's disease therapy: an update. Ann Rev Pharmacol Toxicol, 32, 467-495.
17. + on catecholamine levels in adrenal glands and heart of rats. Naunyn-Schmiedeberg's Arch Pharmacol, 350, 245-251.
18. + exchanger of renal brush-border membrane vesicles. Am J Physiol, 258, F597-F605.
19. + in freshly isolated rat hepatocytes: evidence for interaction with catecholamines. Naunyn-Schmiedeberg's Arch Pharmacol, 354, 305-311.
20. Martel F, Calhau C & Hipólito-Reis C (1998) Effect of bile duct obstruction on hepatic uptake of 1-methyl-4-phenylpyridinium in the rat. Pharmacol Res, 37, 497-504.
21. + in human intestinal epithelial (Caco-2) cells. Naunyn-Schmideberg's Arch Pharmacol, 361, 505-513.
22. 3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: putative involvement of a P-glycoprotein transporter. Br J Pharmacol, 119, 1519-1524.
23. Martel F, Vetter T, Russ H, Gründemann D, Azevedo I, Koepsell H & Schömig E (1996b) Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn-Schmiedeberg's Arch Pharmacol, 354, 320-326.
24. Martel F, Martins MJ, Calhau C, Hipólito-Reis C & Azevedo I (1998) Postnatal development of organic cation transport in the rat liver. Pharmacol Res, 37, 131-136.
25. 2 and rOCT1: effects of catecholamines, metanephrines and corticosterone. Naunyn-Schmiedeberg's Arch Pharmacol, 359, 303-309.
26. Martel F, Gründemann D, Calhau C & Schömig E (2001a) Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. Naunyn-Schmideberg's Arch Pharmacol, 363, 40-49.
27. + in an immortalized rat brain microvessel endothelial cell line (RBE 4). Naunyn-Schmideberg's Arch Pharmacol, 363, 1-10.
28. Melamed E, Rosenthal J, Cohen O, Globus M & Uzzan A (1985) Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. Eur J Pharmacol, 116, 179-181.
29. Motulsky HJ, Spannard P & Neubig R (1994) Graphpad Prism (version 1.0). San Diego: Graphpad Prism Software.
30. Owens MJ, Morgan WN, Plott SJ & Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther, 283, 1305-1322.
31. Pileblad E & Carlssson A (1985) Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology, 24, 689-692.
32. Prasad PD, Hoffmans BJ, Moe AJ, Smith CH, Leibach FH & Ganapathy V (1996) Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta, 17, 201-207.
33. Ramamoorthy S, Leibach FH, Mahesh VB & Ganapathy V (1992) Active transport of dopamine in human placental brush-border membrane vesicles. Am J Physiol, 262(Cell Physiol, 31), C1189-C1196.
34. Ramamoorthy S, Prasad PD, Kulanthaivel P, Leibach FH, Blakely RD & Ganapathy V (1993) Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. Biochemistry, 32, 1346-1353.
35. +). Naunyn-Schmiedeberg's Arch Pharmacol, 346, 158-165.
36. Russ H, Sonna J, Keppler K, Baunach S & Schömig E (1993) Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn-Schmiedeberg's Arch Pharmacol, 348, 458-465.
37. Russ H, Staudt K, Martel F, Gliese M & Schömig E (1996) The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci, 8, 1256-1264.
38. Sayre LM (1989) Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Lett, 48, 121-149.
39. Scholze P, Zwach J, Kattinger A, Pifl C, Singer EA & Sitte HH (2000) Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter. J Pharmacol Exp Ther, 293, 870-878.
40. Sitte HH, Hiptmair B, Zwach J, Pifl C, Singer EA & Scholze P (2001) Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol Pharmacol, 59, 1129-1137.
41. Sokol PP, Holohan PD & Ross CR (1987) The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles. J Pharmacol Exp Ther, 242, 152-157.
42. 2) in human glioma cells. Naunyn-Schmiedeberg's Arch Pharmacol, 353, 328-333.
43. 2) and evidence for the expression of the transporter in the brain. J Biol Chem, 273, 32776-32786.
44. Wu X, Huang W, Ganapathy ME, Wang H, Kekuda R, Conway SJ, Leibach FH & Ganapathy V (2000b) Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am J Physiol, (Renal Physiol), 279, F449-F458.
45. Wu X, George RL, Huang W, Wang H, Conway SJ, Leibach FH & Ganapathy V (2000) Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta, 1466, 315-327.
46. Zhang L, Brett CM & Giacomini KM (1998) Role of organic cation transporters in drug absorption and elimination. Ann Rev Pharmacol Toxicol, 38, 431-460.
47. Zwart R, Verhaagh S, Buitelaar M, Popp-Snijders C & Barlow DP (2001) Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol Cell Biol, 21, 4188-4196.